Back

Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations

7 April 2022 (09:30 - 14:00)
Organised by:
Congress Presentation Part of: Rapid fire abstracts session 2 - Primary Care and Risk Factor Management Lipid-Lowering Agents EAPC Premium Access ESC Preventive Cardiology 2022

About the speaker

Photo
Mr Jonas Pivoriunas

Vestre Viken HF, Drammen (Norway)

4 More presentations in this session

Presentation thumbnail
Long-term effect of obstructive sleep apnea and CPAP treatment on blood pressure control in patients after acute coronary syndrome
Doctor A. Aldoma (Lleida, ES)
Abstract Slides Video
Presentation thumbnail
Anxiety and depressive symptoms in patients with common cardiovascular diseases during hospitalization for COVID-19
Presentation thumbnail
HDL 3: a link between atherosclerosis and thrombosis?
Presentation thumbnail
Meta-analysis of randomized controlled trials examining the safety and efficacy of bempedoic acid
Doctor L. Borgatta (Hershey, US)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid fire abstracts session 2 - Primary Care and Risk Factor Management

The Event

Event poster

ESC Preventive Cardiology 2022

7 April - 9 April 2022
You may be interested in
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
What’s new in LDL lowering?
thumbnail
Congress Presentation
Stepwise approach to lipid-lowering therapies: which one, when, and for whom?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources